Notably, brain inflammation has recently been proposed to underlie defective neuronal insulin signaling (Bomfim et al., 2012; Lourenco et al., 2013), as well as peripheral metabolic deregulation in AD (Clarke et al., 2015). The gene discussed is INS; the disease is Alzheimer disease.